Tirzepatide
A dual GIP/GLP-1 receptor agonist, one of the most referenced compounds in current incretin and metabolic research.
When a customer purchases a peptide, it comes in powder form; we provide a vial of bacteriostatic water for reconstitution and use.
Cada peptídeo + 1 vial water freeLaboratory Spec Sheet
Reagent Synthesis Profile
Tirzepatide is a dual-agonist peptide acting on both GIP and GLP-1 receptors, and is among the most extensively documented compounds in current metabolic and incretin research literature.
Our 5mg vial is manufactured to research-grade specifications and independently tested for identity and purity.
Shipped lyophilized for stability, with a free bacteriostatic water vial included for laboratory reconstitution.
Product FAQ
What receptors does Tirzepatide target?＋
It is a dual agonist acting on both GIP and GLP-1 receptors.
How does this differ from Retatrutide?＋
Tirzepatide acts on two receptor pathways (GIP/GLP-1), while Retatrutide is a triple agonist that also targets glucagon receptors.
